Yuyu Pharma Inc (000225) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.021x

Based on the latest financial reports, Yuyu Pharma Inc (000225) has a cash flow conversion efficiency ratio of 0.021x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.95 Billion ≈ $2.00 Million USD) by net assets (₩142.56 Billion ≈ $96.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000225 net asset quality index to measure how much of total assets are equity-financed.

Yuyu Pharma Inc - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Yuyu Pharma Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Yuyu Pharma Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Yuyu Pharma Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yuyu Pharma Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
TCS Group Holdings Bhd KLSE:0221	-0.056x
Euromedis Groupe SA PA:ALEMG	0.048x
MSCM Holdings Bhd KLSE:0041	-0.048x
Bina Darulaman Bhd KLSE:6173	-0.030x
Gigasun AB ST:GIGA	0.132x
First Media Tbk JK:KBLV	-0.001x
Xintela AB ST:XINT	0.242x
BALAXI PHARMACEUTICALS LIMITED NSE:BALAXI	0.063x

Annual Cash Flow Conversion Efficiency for Yuyu Pharma Inc (2014–2025)

The table below shows the annual cash flow conversion efficiency of Yuyu Pharma Inc from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Yuyu Pharma Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩140.54 Billion ≈ $95.24 Million	₩15.88 Billion ≈ $10.76 Million	0.113x	-38.84%
2024-12-31	₩135.06 Billion ≈ $91.53 Million	₩24.95 Billion ≈ $16.91 Million	0.185x	+5182.83%
2023-12-31	₩120.36 Billion ≈ $81.56 Million	₩420.86 Million ≈ $285.21K	0.003x	+106.93%
2022-12-31	₩123.37 Billion ≈ $83.61 Million	₩-6.23 Billion ≈ $-4.22 Million	-0.050x	-244.10%
2021-12-31	₩128.69 Billion ≈ $87.21 Million	₩4.51 Billion ≈ $3.06 Million	0.035x	+253.64%
2020-12-31	₩117.04 Billion ≈ $79.31 Million	₩-2.67 Billion ≈ $-1.81 Million	-0.023x	-115.66%
2019-12-31	₩90.54 Billion ≈ $61.36 Million	₩13.19 Billion ≈ $8.94 Million	0.146x	+107.05%
2018-12-31	₩86.87 Billion ≈ $58.87 Million	₩6.11 Billion ≈ $4.14 Million	0.070x	+937.85%
2017-12-31	₩82.83 Billion ≈ $56.14 Million	₩561.35 Million ≈ $380.42K	0.007x	-94.60%
2016-12-31	₩78.29 Billion ≈ $53.06 Million	₩9.82 Billion ≈ $6.65 Million	0.125x	+179.12%
2015-12-31	₩73.73 Billion ≈ $49.97 Million	₩-11.68 Billion ≈ $-7.92 Million	-0.158x	-930.90%
2014-12-31	₩71.49 Billion ≈ $48.45 Million	₩1.36 Billion ≈ $923.95K	0.019x	--

About Yuyu Pharma Inc

KO:000225 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$14.10 Million

₩20.80 Billion KRW

Market Cap Rank

#26165 Global

#1962 in Korea

Share Price

₩3550.00

Change (1 day)

+1.57%

52-Week Range

₩3375.00 - ₩5250.00

All Time High

₩25149.31